Skip to content
CDLX Cardlytics Inc NASDAQ
5.29 USD -4.68% -0.26
OPEN 5.71
PREV CLOSE 5.55
DAY RANGE 5.88 - 5.26
VOLUME 596.8K
AVG. VOLUME 461.4K
52 WEEK RANGE 29.85 - 2.57
Interactive Brokers Logotype

Buy CDLX stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 179.4M
Enterprise value 315.1M
Trailing pe -0.38002873563218
Forward pe -3.5033112
Peg ratio -3.5033112
Price to sales ttm 0.60816216
Price to book mrq 0.76666665
Enterprise to revenue 1.068
Enterprise to ebitda -3.981

Financials

Fiscal year ends 2022-12-31
Most recent quarter 2023-03-31
Profit margin -1.64334
Operating margin -0.38446
Return on assets ttm -0.07399
Return on equity ttm -1.0269
Income statement
Revenue ttm 294.9M
Revenue per share ttm 8.835
Quarterly revenue growth -0.053
Gross profit ttm 115.4M
Ebitda -79148000
Net income to common ttm -484694016
Diluted eps ttm -13.51
Quarterly earnings growth yoy -0.588
Balance sheet
Total cash mrq 139.2M
Total cash per share mrq 4.105
Total debt mrq 266.1M
Total debt to equity mrq 114.552
Current ratio mrq 1.291
Book value per share mrq 6.9
Cash flow
Operating cash flow ttm -44277000
Levered free cash flow ttm -56635124

Stock statistics

Shares outstanding 33.9M
Float shares 26M
Avg 10 volume 457.6K
Avg 30 volume 0.9M
Shares short 4.9M
Short ratio 3.79
Short percent of shares outstanding 0.1725
Percent held by insiders 0.02957
Percent held by institutions 0.90694

Stock price summary

Fifty two week low 2.57
Fifty two week high 29.85
Fifty two week change -424.575
Beta 1.758972
Day 50 ma 5.7608
Day 200 ma 6.775175

Dividends and splits

Cardlytics, Inc. (CDLX) company profile

Cardlytics Inc. (NASDAQ: CDLX) is an American company that offers transaction-driven marketing solutions through software that analyzes and reports customers based on their purchasing history.

In developing marketing solutions the company leverages its purchase intelligence platform. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008, with headquarters in Atlanta, Georgia, in the United States.

Cardlytics trades on the Nasdaq exchange under the ticker CDLX having gone public in February 2018.

Cardlytics operates under two segments, Cardlytics Direct, and Other Platform Solutions. The Cardlytics Direct segment is the company’s proprietary native bank advertising platform. The Other Platform Solutions segment entails solutions that enable marketers and marketing service providers to build on the power of purchase intelligence outside the banking channel. Cardlytics also allows consumers to earn cash back on their purchases.

Some of Cardlytics main competitors 

  • Loyyal;
  • OptioPay;
  • Switchfly;
  • Meniga.

Cardlytics key milestones 

In February 2018, Cardlytics became the first fintech platform to go public in a $70 million IPO on the Nasdaq exchange. 

In July 2020, the company expanded its advertising platform after launching its Wells Fargo deals. The partnership with Wells Fargo offered an advertising platform in the banks’ digital channels. Also, in 2020, Cardlytics acquired Bridg, a customer data platform that empowers marketers to understand better and reach customers using SKU-level insights.

In May 2021, Cardlytics partnered with fintech platform Curve to offer their customers the full benefits of Cardlytics’ rewards model.

FAQs about CDLX stock

Does Cardlytics (CDLX) stock pay dividends?

No, Cardlytics does not pay dividends.

Has Cardlytics stock (CDLX) ever split?

Since going public, cardlytics has had 0 splits.

Where is Cardlytics located globally?

Headquartered in Atlanta, Cardlytics has offices in London, New York, San Francisco and Visakhapatnam.  

How many companies has Cardlytics acquired?

Since its establishment, Cardlytics has been involved in two high-profile acquisitions of Bridg and Dosh.